Literature DB >> 24434833

Perspective on combination RAS blocking therapy: off-TARGET, dis-CORD, MAP-to-nowhere, low ALTITUDE, and NEPHRON-D.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24434833     DOI： 10.1159/000357593

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN： 0250-8095            Impact factor:   3.754


× No keyword cloud information.
  3 in total

1.  Preserving kidney health during intensive blood pressure control.

Authors:  Maria Luisa S Sequeira-Lopez; R Ariel Gomez
Journal:  Nat Rev Nephrol       Date:  2018-09       Impact factor: 28.314

Review 2.  Renin Cells, the Kidney, and Hypertension.

Authors:  Maria Luisa S Sequeira-Lopez; R Ariel Gomez
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

3.  Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy.

Authors:  David G Warnock; Christie P Thomas; Bojan Vujkovac; Ruth C Campbell; Joel Charrow; Dawn A Laney; Leslie L Jackson; William R Wilcox; Christoph Wanner
Journal:  J Med Genet       Date:  2015-10-21       Impact factor: 6.318
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.